3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
235
Lymphoma
160
Leukemia
109
Burkitt Lymphoma
91
Lymphoma, Non-Hodgkin
85
Lymphoma, Large B-Cell, Diffuse
80
Lymphoma, Mantle-Cell
70
Leukemia, Myeloid, Acute
53
Lymphoma, Follicular
49
Hodgkin Disease
44
Lymphoma, Large-Cell, Immunoblastic
37
Leukemia, Lymphocytic, Chronic, B-Cell
33
Recurrence
32
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
28
Lymphoma, B-Cell, Marginal Zone
24
Leukemia, Biphenotypic, Acute
24
Myelodysplastic Syndromes
23
Blast Crisis
19
Lymphoma, Large-Cell, Anaplastic
18
Lymphoma, B-Cell
18
Dendritic Cell Sarcoma, Interdigitating
17
Congenital Abnormalities
17
Leukemia, Myeloid, Accelerated Phase
16
Leukemia, Myelomonocytic, Chronic
15
Multiple Myeloma
12
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, T-Cell
11
Myeloproliferative Disorders
10
Anemia, Refractory, with Excess of Blasts
10
Neoplasms, Plasma Cell
9
Interventions
Etoposide
4
pegaspargase
3
Cyclophosphamide
3
Methylprednisolone
2
Gemcitabine
2
Flow Cytometry
2
Dexamethasone
2
Alemtuzumab
2
zanubrutinib
1
sintilimab
1
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
Whole-Body Irradiation
1
Vincristine
1
Thiotepa
1
Th1-Th2 Balance
1
Tacrolimus
1
Rituximab
1
Prednisone
1
Polymerase Chain Reaction
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Methylprednisolone Hemisuccinate
1
Melphalan
1
In Situ Hybridization
1
Immunohistochemistry
1
EPOCH protocol
1
Doxorubicin
1
Cytogenetic Analysis
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphohistiocytosis, Hemophagocytic
×
Cytarabine
×
Lymphoid
×
Clear all
NCT00368355
2020-01-21
MOHEL
Baylor College of Medicine
Phase 2
Completed
46 enrolled
12 charts